Breakthrough Drug Nearly Doubles Survival With Advanced Pancreatic Cancer – An Oncologist Explains How Daraxonrasib Overcame An ‘Undruggable’ Disease

For a long time, the likelihood of surviving pancreatic cancer has been extremely low. For patients who were diagnosed with metastatic pancreatic cancer between 2015 and 2021, about 97% died within five years of their diagnosis.